WEBSITE BSE:519003 NSE: MODINATURAL Inc. Year: 1974 Industry: Edible Oil My Bucket: Add Stock
Last updated: 15:52
Modi Naturals Ltd is engaged in production and advertising of fit to be eaten oils and de-oiled cakes. The Company offers client merchandise and B2B products. Its consumer products' manufacturers include Oleev, Olivana, Rizolo, Miller and Tarai. Its B2B merchandise include Rice Bran Oil, Sunflower Oil, Mustard Oil, Rice Bran Wax, Distilled Fatty Acids, De-oiled Rice Bran and De-oiled Sunflower Cake. Its Oleev logo consists of olive oils. The Rizolo emblem offers rice bran oil. Its Olivana Wellness brand includes massage oils. Its branded produc...Read More
Modi Naturals Ltd is engaged in production and advertising of fit to be eaten oils and de-oiled cakes. The Company offers client merchandise and B2B products. Its consumer products' manufacturers include Oleev, Olivana, Rizolo, Miller and Tarai. Its B2B merchandise include Rice Bran Oil, Sunflower Oil, Mustard Oil, Rice Bran Wax, Distilled Fatty Acids, De-oiled Rice Bran and De-oiled Sunflower Cake. Its Oleev logo consists of olive oils. The Rizolo emblem offers rice bran oil. Its Olivana Wellness brand includes massage oils. Its branded product portfolio includes Rizolo Rice bran oil, Tarai shudh Mustard oil, Tarai Tasty+ (Blend of mustard and rice bran oil), Oleev Olive oil, Oleev Active oil (Blend of Olive oil and Rice Bran Oil), Mi ller Canola Oil and Olivana Wellness Oil. The Company's plant is placed in Uttar Pradesh, India. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹480 Cr.
Stock P/E 15.5
P/B 3.2
Current Price ₹361
Book Value ₹ 114.2
Face Value 10
52W High ₹609.9
Dividend Yield 0%
52W Low ₹ 261
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 92 | 104 | 120 | 148 | 147 | 179 | 190 | 155 | 147 | 174 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
| Total Income | 92 | 105 | 120 | 148 | 147 | 180 | 190 | 155 | 148 | 174 |
| Total Expenditure | 90 | 106 | 114 | 134 | 133 | 166 | 174 | 137 | 132 | 158 |
| Operating Profit | 2 | -1 | 6 | 13 | 14 | 14 | 16 | 18 | 16 | 16 |
| Interest | 1 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
| Depreciation | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | -5 | 1 | 9 | 9 | 9 | 11 | 13 | 12 | 12 |
| Provision for Tax | 0 | -1 | 0 | 1 | 1 | 1 | 3 | 3 | 2 | 2 |
| Profit After Tax | 1 | -4 | 1 | 7 | 8 | 8 | 8 | 10 | 10 | 10 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | -4 | 1 | 7 | 8 | 8 | 8 | 10 | 10 | 10 |
| Adjusted Earnings Per Share | 0.6 | -3.1 | 0.9 | 5.6 | 5.7 | 5.9 | 6.1 | 7.9 | 7.6 | 7.5 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Net Sales | 443 | 474 | 418 | 400 | 663 | 666 |
| Other Income | 4 | 1 | 2 | 1 | 1 | 1 |
| Total Income | 447 | 476 | 420 | 401 | 664 | 667 |
| Total Expenditure | 430 | 459 | 413 | 391 | 607 | 601 |
| Operating Profit | 17 | 16 | 7 | 10 | 57 | 66 |
| Interest | 1 | 2 | 4 | 7 | 12 | 9 |
| Depreciation | 1 | 1 | 2 | 4 | 8 | 8 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 14 | 13 | 2 | -2 | 38 | 48 |
| Provision for Tax | 3 | 4 | 1 | -0 | 7 | 10 |
| Profit After Tax | 11 | 9 | 1 | -1 | 31 | 38 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 11 | 9 | 1 | -1 | 31 | 38 |
| Adjusted Earnings Per Share | 8.3 | 7.4 | 0.8 | -1 | 23.3 | 29.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 66% | 12% | 0% | 0% |
| Operating Profit CAGR | 470% | 53% | 0% | 0% |
| PAT CAGR | 0% | 51% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -10% | 15% | 39% | 9% |
| ROE Average | 29% | 10% | 12% | 12% |
| ROCE Average | 19% | 8% | 11% | 11% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Shareholder's Funds | 68 | 77 | 82 | 91 | 122 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 88 | 86 | 71 |
| Other Non-Current Liabilities | 5 | 5 | 5 | 4 | 8 |
| Total Current Liabilities | 48 | 83 | 88 | 126 | 130 |
| Total Liabilities | 121 | 165 | 263 | 306 | 330 |
| Fixed Assets | 19 | 26 | 27 | 149 | 145 |
| Other Non-Current Assets | 1 | 7 | 94 | 1 | 26 |
| Total Current Assets | 99 | 132 | 135 | 156 | 159 |
| Total Assets | 121 | 165 | 263 | 306 | 330 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 0 | 4 | 2 | 0 |
| Cash Flow from Operating Activities | 9 | -13 | -6 | -7 | 49 |
| Cash Flow from Investing Activities | 2 | -13 | -91 | -32 | -28 |
| Cash Flow from Financing Activities | -12 | 30 | 95 | 37 | -21 |
| Net Cash Inflow / Outflow | -1 | 4 | -2 | -2 | -0 |
| Closing Cash & Cash Equivalent | 0 | 4 | 2 | 0 | 0 |
| # | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 8.31 | 7.4 | 0.84 | -1.04 | 23.32 |
| CEPS(Rs) | 9.4 | 8.52 | 2.07 | 2.13 | 29.19 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 52.31 | 60.41 | 56.6 | 68.1 | 91.24 |
| Core EBITDA Margin(%) | 2.91 | 3.17 | 1.3 | 2.31 | 8.47 |
| EBIT Margin(%) | 3.49 | 3.15 | 1.35 | 1.43 | 7.47 |
| Pre Tax Margin(%) | 3.16 | 2.73 | 0.44 | -0.43 | 5.69 |
| PAT Margin (%) | 2.38 | 1.97 | 0.26 | -0.34 | 4.68 |
| Cash Profit Margin (%) | 2.69 | 2.27 | 0.63 | 0.71 | 5.86 |
| ROA(%) | 8.68 | 6.54 | 0.5 | -0.48 | 9.76 |
| ROE(%) | 15.88 | 13.13 | 1.44 | -1.7 | 29.27 |
| ROCE(%) | 17.82 | 13.94 | 3.26 | 2.39 | 18.68 |
| Receivable days | 17.28 | 15.37 | 16.77 | 21.34 | 20.66 |
| Inventory Days | 56.22 | 62.37 | 77.9 | 82.42 | 49.5 |
| Payable days | 8.23 | 10.19 | 17.55 | 28.27 | 21.01 |
| PER(x) | 8.79 | 26.62 | 276 | 0 | 14.67 |
| Price/Book(x) | 1.4 | 3.26 | 4.12 | 2.81 | 3.75 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.25 | 0.62 | 1.04 | 1.06 | 0.91 |
| EV/Core EBITDA(x) | 6.66 | 18.07 | 60.33 | 42.58 | 10.48 |
| Net Sales Growth(%) | 0 | 7.14 | -11.88 | -4.34 | 65.8 |
| EBIT Growth(%) | 0 | -3.43 | -62.32 | 1.47 | 767.73 |
| PAT Growth(%) | 0 | -10.94 | -88.59 | -229 | 2350.85 |
| EPS Growth(%) | 0 | -10.94 | -88.59 | -222.71 | 2350.84 |
| Debt/Equity(x) | 0.31 | 0.67 | 1.99 | 1.87 | 1.23 |
| Current Ratio(x) | 2.06 | 1.59 | 1.53 | 1.24 | 1.22 |
| Quick Ratio(x) | 0.64 | 0.46 | 0.57 | 0.48 | 0.58 |
| Interest Cover(x) | 10.36 | 7.55 | 1.49 | 0.77 | 4.18 |
| Total Debt/Mcap(x) | 0.22 | 0.2 | 0.48 | 0.67 | 0.33 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 | 69.09 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 30.85 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 | 30.91 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 | 0.92 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 | 1.33 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
